The Alan S. Crandall Center for Glaucoma Innovation conducts independent preclinical, clinical, and comparative research, with a focus on glaucoma diagnostics and therapeutics, including micro-invasive glaucoma surgery (MIGS) devices. Our dedicated clinical research staff and fellowship-trained glaucoma faculty support this research.
The center gathers data on device biocompatibility, safety, and efficacy by conducting laboratory research using in vitro and in vivo methods.
The center oversees testing using pilot, pivotal, and post-approval studies to evaluate safety, efficacy, and long-term performance of devices.
The center evaluates device-related outcomes, analyzing tissue samples and patient records in a controlled laboratory environment.
The center conducts comparative research to evaluate materials, designs, and placement of devices.